Higher IDO1 expression has been observed in breast cancer [6, 11, 27] and other cancers [11], including colorectal cancer, esophageal carcinoma, cervical squamous cell carcinoma, melanoma, and pancreatic cancer. Here, IDO1 is linked to pancreatic neoplasm.